243 related articles for article (PubMed ID: 31433724)
1. Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor.
Yang T; Feng YL; Chen L; Vaziri ND; Zhao YY
Crit Rev Toxicol; 2019 May; 49(5):445-460. PubMed ID: 31433724
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma.
Zhao H; Chen L; Yang T; Feng YL; Vaziri ND; Liu BL; Liu QQ; Guo Y; Zhao YY
J Transl Med; 2019 Sep; 17(1):302. PubMed ID: 31488157
[TBL] [Abstract][Full Text] [Related]
3. Aryl Hydrocarbon Receptor Diet and Breast Cancer Risk.
Donovan MG; Selmin OI; Romagnolo DF
Yale J Biol Med; 2018 Jun; 91(2):105-127. PubMed ID: 29962921
[TBL] [Abstract][Full Text] [Related]
4. Plant Occurring Flavonoids as Modulators of the Aryl Hydrocarbon Receptor.
Goya-Jorge E; Jorge Rodríguez ME; Veitía MS; Giner RM
Molecules; 2021 Apr; 26(8):. PubMed ID: 33923487
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor: An emerging player in breast cancer pathogenesis and its potential as a drug target (Review).
Chen C; Wang Z; Liao Z; Zhang Y; Lei W; Shui X
Mol Med Rep; 2024 Jan; 29(1):. PubMed ID: 37997818
[TBL] [Abstract][Full Text] [Related]
6. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially.
Ciolino HP; Daschner PJ; Yeh GC
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):715-22. PubMed ID: 10359656
[TBL] [Abstract][Full Text] [Related]
7. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target.
Kolluri SK; Jin UH; Safe S
Arch Toxicol; 2017 Jul; 91(7):2497-2513. PubMed ID: 28508231
[TBL] [Abstract][Full Text] [Related]
8. The bioflavonoid galangin blocks aryl hydrocarbon receptor activation and polycyclic aromatic hydrocarbon-induced pre-B cell apoptosis.
Quadri SA; Qadri AN; Hahn ME; Mann KK; Sherr DH
Mol Pharmacol; 2000 Sep; 58(3):515-25. PubMed ID: 10953044
[TBL] [Abstract][Full Text] [Related]
9. Indole scaffolds as a promising class of the aryl hydrocarbon receptor ligands.
Dvořák Z; Poulíková K; Mani S
Eur J Med Chem; 2021 Apr; 215():113231. PubMed ID: 33582577
[TBL] [Abstract][Full Text] [Related]
10. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
[TBL] [Abstract][Full Text] [Related]
11. Aryl Hydrocarbon Receptor as an Anticancer Target: An Overview of Ten Years Odyssey.
Hanieh H; Bani Ismail M; Alfwuaires MA; Ibrahim HM; Farhan M
Molecules; 2023 May; 28(10):. PubMed ID: 37241719
[TBL] [Abstract][Full Text] [Related]
12. [Aryl-hydrocarbon receptor as a potential target for anticancer therapy].
Vorontsova JE; Cherezov RO; Kuzin BA; Simonova OB
Biomed Khim; 2018 Sep; 64(5):397-415. PubMed ID: 30378556
[TBL] [Abstract][Full Text] [Related]
13. Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor.
Reiners JJ; Clift R; Mathieu P
Carcinogenesis; 1999 Aug; 20(8):1561-6. PubMed ID: 10426807
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor-mediated cell cycle control.
Elferink CJ
Prog Cell Cycle Res; 2003; 5():261-7. PubMed ID: 14593720
[TBL] [Abstract][Full Text] [Related]
16. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.
Novikov O; Wang Z; Stanford EA; Parks AJ; Ramirez-Cardenas A; Landesman E; Laklouk I; Sarita-Reyes C; Gusenleitner D; Li A; Monti S; Manteiga S; Lee K; Sherr DH
Mol Pharmacol; 2016 Nov; 90(5):674-688. PubMed ID: 27573671
[TBL] [Abstract][Full Text] [Related]
17. Reduction of CC-chemokine ligand 5 by aryl hydrocarbon receptor ligands.
Morino-Koga S; Uchi H; Tsuji G; Takahara M; Kajiwara J; Hirata T; Furue M
J Dermatol Sci; 2013 Oct; 72(1):9-15. PubMed ID: 23810773
[TBL] [Abstract][Full Text] [Related]
18. Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention.
Okino ST; Pookot D; Basak S; Dahiya R
Cancer Prev Res (Phila); 2009 Mar; 2(3):251-6. PubMed ID: 19223575
[TBL] [Abstract][Full Text] [Related]
19. Herbal Plants: The Role of AhR in Mediating Immunomodulation.
Bungsu I; Kifli N; Ahmad SR; Ghani H; Cunningham AC
Front Immunol; 2021; 12():697663. PubMed ID: 34249001
[TBL] [Abstract][Full Text] [Related]
20. Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation.
Hubbard TD; Murray IA; Perdew GH
Drug Metab Dispos; 2015 Oct; 43(10):1522-35. PubMed ID: 26041783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
